Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients

FRIDAY, July 2, 2021 -- Patients with multiple myeloma (MM) mount a highly variable antibody response after receipt of a two-dose mRNA COVID-19 vaccination regimen, according to a study published online June 28 in Cancer Cell. Oliver Van Oekelen,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news